| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |